IVAX Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 10,100


  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 6

IVAX General Information


Manufacturer and developer of generic pharmaceuticals and veterinary products. The company's activities include research, development, manufacturing and marketing of generic pharmaceuticals and veterinary products, enabling customers to have quality products.

Contact Information

Ownership Status
Financing Status
Primary Industry
Other Industries
Drug Delivery
Corporate Office
  • 4400 Biscayne Boulevard
  • Miami, FL 33137
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IVAX Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IVAX‘s full profile, request access.

Request a free trial

IVAX Executive Team (1)

Name Title Board Seat Contact Info
Phillip Frost MD Founder, Chief Executive Officer & Chairman
To view IVAX’s complete executive team members history, request access »

IVAX Board Members (1)

Name Representing Role Since
0000000 00000 00 Self Founder, Chief Executive Officer & Chairman 000 0000
To view IVAX’s complete board members history, request access »

IVAX Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IVAX Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Phoenix Scientific 11-May-2005 0000000000 00000 Pharmaceuticals
Elan (Nasarel and Nasalide Product Lines, patents and trademarks) 01-Oct-2001 000000000 00000 Buildings and Property
ERBA Diagnostics 15-Mar-2001 0000000 00 Diagnostic Equipment 0000000 0
Zenith Laboratories 29-Aug-1994 0000000000 00000 Pharmaceuticals 0000000 0
McGaw Laboratories 05-Jan-1994 Merger/Acquisition 00000 Medical Supplies
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

IVAX Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
ERBA Diagnostics 15-Mar-2001 0000000 000000 Completed
  • 0000
McGaw Laboratories 05-Jan-1994 000000000000000000 00000 Completed
  • 0000
Johnson Products 31-Aug-1993 Merger/Acquisition 000.00 Completed
To view IVAX’s complete exits history, request access »


  • Who is the founder of IVAX?

    Phillip Frost MD is the founder of IVAX.

  • Who is the CEO of IVAX?

    Phillip Frost MD is the CEO of IVAX.

  • Where is IVAX headquartered?

    IVAX is headquartered in Miami, FL.

  • What is the size of IVAX?

    IVAX has 10,100 total employees.

  • What industry is IVAX in?

    IVAX’s primary industry is Pharmaceuticals.

  • Is IVAX a private or public company?

    IVAX is a Private company.

  • What is the current valuation of IVAX?

    The current valuation of IVAX is 00.00.

  • What is IVAX’s current revenue?

    The current revenue for IVAX is 00000.

  • How much funding has IVAX raised over time?

    IVAX has raised $1.08B.

  • When was IVAX acquired?

    IVAX was acquired on 26-Jan-2006.

  • Who acquired IVAX?

    IVAX was acquired by Teva Pharmaceutical Industries.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »